Lord, Abbett & Co’s Veracyte VCYT Stock Holding History

Lord, Abbett & Co’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-234,692	Closed	-$6.96M	–	589
2025 Q1	$6.96M	Sell	234,692 -154,914	-40%	-$5.9M	0.02%	421
2024 Q4	$15.4M	Buy	389,606 +110,574	+40%	+$4.19M	0.05%	353
2024 Q3	$9.5M	Buy	+279,032	New	+$7.85M	0.03%	411
2021 Q2	–	Sell	-182,284	Closed	-$9.8M	–	716
2021 Q1	$9.8M	Sell	182,284 -68,492	-27%	-$3.95M	0.03%	528
2020 Q4	$12.3M	Buy	250,776 +65,608	+35%	+$3.04M	0.03%	490
2020 Q3	$6.02M	Buy	185,168 +31,056	+20%	+$987K	0.02%	548
2020 Q2	$3.99M	Sell	154,112 -82,180	-35%	-$2.05M	0.01%	587
2020 Q1	$5.74M	Sell	236,292 -207,738	-47%	-$5.23M	0.03%	515
2019 Q4	$12.4M	Buy	444,030 +288,188	+185%	+$7.46M	0.04%	483
2019 Q3	$3.74M	Buy	+155,842	New	+$4.15M	0.01%	650

Other funds holding VCYT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co's VCYT Position: Q2 2025 in Review

Lord, Abbett & Co sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 234,692 shares — an estimated $6.96M sold.

Lord, Abbett & Co first reported a position in VCYT in Q3 2019 and held it in 10 quarters. The position peaked at $15.4M in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

Lord, Abbett & Co reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
Lord, Abbett & Co sold 234,692 Veracyte shares in Q2 2025, an estimated $6.96M.
Lord, Abbett & Co first reported a position in Veracyte in Q3 2019 and held it in 10 quarters.
Lord, Abbett & Co's Veracyte position peaked at $15.4M in Q4 2024.
278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Lord, Abbett & Co's 13F filing for Q2 2025, filed 14 Aug 2025.